The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Toronto Dominion Bank

Toronto Dominion Bank lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 15.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,772 shares of the medical device company’s stock after acquiring an additional 8,900 shares during the period. Toronto Dominion Bank’s holdings in Cooper Companies were worth $7,368,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC grew its stake in Cooper Companies by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 6,797 shares of the medical device company’s stock worth $593,000 after acquiring an additional 184 shares during the period. Blue Trust Inc. grew its position in shares of Cooper Companies by 112.7% in the second quarter. Blue Trust Inc. now owns 553 shares of the medical device company’s stock valued at $48,000 after purchasing an additional 293 shares during the period. Raymond James & Associates increased its stake in Cooper Companies by 4.4% in the second quarter. Raymond James & Associates now owns 647,106 shares of the medical device company’s stock valued at $56,492,000 after purchasing an additional 27,442 shares during the last quarter. First Horizon Advisors Inc. lifted its position in Cooper Companies by 4.8% during the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after buying an additional 125 shares during the period. Finally, Fifth Third Bancorp boosted its stake in Cooper Companies by 6.3% in the 2nd quarter. Fifth Third Bancorp now owns 8,465 shares of the medical device company’s stock worth $739,000 after buying an additional 502 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.9 %

NASDAQ:COO opened at $94.85 on Friday. The business’s 50-day moving average is $103.49 and its two-hundred day moving average is $98.92. The firm has a market capitalization of $18.93 billion, a PE ratio of 48.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s revenue was up 9.8% on a year-over-year basis. During the same period last year, the business posted $0.87 EPS. Research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Piper Sandler upped their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday. Finally, Stifel Nicolaus restated a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.